Dr. Travis Bond, MD, MBA, is the Founder and CEO of Bioinsights, a Clinical Operating System for Root-Cause Medicine built to help functional and integrative medicine providers think faster, treat smarter, and scale with confidence.

Dr. Bond holds dual MBAs from UCLA Anderson and the National University of Singapore, combining deep medical training with elite business acumen across 25+ years of healthcare technology leadership.

Dr. Bond pioneered the patented Predictive Dysfunction Index (PDI), translating complex patient data into actionable cellular-level insights, with his technologies now deployed in 18 countries.

He previously founded Bond Technologies, creator of the world's first certified browser-based EHR (acquired by Allscripts), built CareSync into the largest Chronic Care Management company in the US, and served as CEO of Altoida where he secured FDA Breakthrough Device Designation for an AI and AR-based cognitive assessment platform.

Bioinsights was selected to participate in the MAHA initiative for its AI-powered bridge between traditional and functional medicine, and has raised $2.75M toward a $7.9M equity offering with 40,000+ patient encounters informing its clinical protocols.